|
This Undervalued Company's Expansion
Plans Could Spell Big Gains
This discount grocer hired a former
Wal-Mart exec as its CEO and is already
seeing results. An aggressive plan to
open 100 new discount stores should lead
to big gains for shareholders in the
years ahead.
The Stock to Own in this Out-of-Favor
Sector
This high-flying airline should flourish
in a rising economy, but its balance
sheet should also provide a strong
cushion if we hit bumpy skies again.
The Most Important Thing to Remember as
an Investor in Oil
It's hard to know exactly how much oil
will cost in a few months. The best bet
oil investors have is to buy oil so low,
that it can't get any cheaper. And guess
what, it's easier than you think.
Why 2010 is THE Year for This Investment
An improving economy and historically
low valuations have created an ideal
situation for this sector.
An Undervalued Industry Leader with +66%
Upside Potential
This insurance company has increased its
dividend for 26 straight years, grown
revenue for more than a decade and
trades at a steep discount to its
historical valuations. Shares could jump
+66% as they approach their historic
valuation.
Looking Beyond Banks to Uncover Truly
Excellent Value
Bank balance sheets might make banks
seem like great values, though very few
are. These two securities, however,
sidestep the minefield of financial
institutions and not only offer
investors a truly good deal but also
offer rich dividend income.
Don't Miss the Best Pharma Value on the
Market
One of the market's most well-known drug
giants is trading at single digit
valuations -- a value that won't last
long. Plus, the company has paid
dividends for more than 120 years and
yields 5.5%.
Why I'm Buying This Stock
Tuesday's earnings announcement is
likely to provide a pop for these
troubled shares after JP Morgan's
revenue misses expectations and sends
banks lower.
The Company Poised to Rebound with the
Improving Economy
As the long economic downturn subsides,
consumers will begin to re-enter a
market they abandoned when the housing
bubble burst. That's one very good
reason to invest in this industry
leader.
40 Million People Need This Life-Saving
Drug
This pharmaceutical company has the
highest operating margins in the
industry, and it has the exclusive
rights to its money-making drugs for
another decade.
Is
This Tiny Stock the Next
Exxon -- Or the Next
Budweiser?
This investment could make anyone who listens filthy rich. The company
owns a unique living compound with huge potential in the production of
cellulosic ethanol -- a market with +15,900% government-mandated growth
ahead. Who knows how high this stock is headed? I don't. But it's so
cheap now that making 100x your money is possible once the technology
goes mainstream.
Click here for
more details.
|
